Literature DB >> 16496430

Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.

Helga Gardarsdottir1, Eibert R Heerdink, Antoine C G Egberts.   

Abstract

PURPOSE: The aim of this study was to evaluate the effect of the length of the drug free period on incidence measurements as well as on cohort characteristics in users of antidepressants.
METHODS: The study population consisted of patients aged 18 years or older who filled a prescription for an antidepressant drug in the Netherlands, between October 2001 and September 2002. One-year incidence of antidepressant drug use was estimated using drug free periods varying in length from 1 month to 9 years. In addition, we evaluated what effect the drug free period has on cohort characteristics by comparing a cohort of first time antidepressant drug users defined using a 9-year drug free period with cohorts using 6, 12 and 24 months drug free period.
RESULTS: When using a 6-month drug free period the measured incidence was about 32 per 1,000 individuals (95%CI: 31.3, 32.6) while the measured incidence was 27.5 (95%CI: 26.9, 28.1), 23.5 (95%CI: 22.9, 24.0) and 17.2 (95%CI: 16.7, 17.7) per 1,000 individuals when using a 12-month, 24 month respectively a 9-year drug free period. Furthermore, the prevalence of characteristics in inception cohort studies changes when using different drug free periods.
CONCLUSION: Altering the drug free period from a short to a longer one results in decreased incidence. Furthermore, for inception cohorts where first time drug use is an inclusion criterion the drug free period can influence the prevalence of cohort characteristics and for short drug free periods give biased estimates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496430     DOI: 10.1002/pds.1223

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Authors:  Edeltraut Kröger; Rob van Marum; Patrick Souverein; Toine Egberts
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

2.  Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.

Authors:  Andrew W Roberts; Stacie B Dusetzina; Joel F Farley
Journal:  J Comp Eff Res       Date:  2015-01       Impact factor: 1.744

3.  Potential bias in medication adherence studies of prevalent users.

Authors:  Matthew L Maciejewski; Chris L Bryson; Virginia Wang; Mark Perkins; Chuan-Fen Liu
Journal:  Health Serv Res       Date:  2013-02-13       Impact factor: 3.402

4.  A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.

Authors:  Virginie Gardette; Maryse Lapeyre-Mestre; Antoine Piau; Adeline Gallini; Christelle Cantet; Jean-Louis Montastruc; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

5.  Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years.

Authors:  Karolina Andersson Sundell; Mika Gissler; Max Petzold; Margda Waern
Journal:  Eur J Clin Pharmacol       Date:  2010-11-10       Impact factor: 2.953

6.  A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK.

Authors:  Juan Francisco Hernandez; Aukje K Mantel-Teeuwisse; Ghislaine J M W van Thiel; Svetlana V Belitser; Jan Warmerdam; Vincent de Valk; Jan A M Raaijmakers; Toine Pieters
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.

Authors:  Ole Köhler; Liselotte Petersen; Ole Mors; Christiane Gasse
Journal:  Brain Behav       Date:  2015-05-29       Impact factor: 2.708

8.  Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study.

Authors:  Federica Edith Pisa; Jonas Reinold; Bianca Kollhorst; Ulrike Haug; Tania Schink
Journal:  Clin Epidemiol       Date:  2020-06-22       Impact factor: 4.790

9.  Incidence in pharmacoepidemiology-Basic definitions and types of misclassification.

Authors:  Mikael Hoffmann; Henrik Støvring
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-04-13       Impact factor: 3.688

10.  The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA1c/LDL target achievement in newly diagnosed type 2 diabetes.

Authors:  Christopher Rohde; Jakob S Knudsen; Norbert Schmitz; Søren Dinesen Østergaard; Reimar W Thomsen
Journal:  Diabetologia       Date:  2020-10-19       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.